The Open UniversitySkip to content
 

From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry

Kale, Dinar (2018). From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry. Technological Forecasting and Social Change (Early Access).

Full text available as:
Full text not publicly available (Accepted Manuscript)
Due to publisher licensing restrictions, this file is not available for public download until 24 March 2020
Click here to request a copy from the OU Author.
DOI (Digital Object Identifier) Link: https://doi.org/10.1016/j.techfore.2018.09.020
Google Scholar: Look up in Google Scholar

Abstract

Technology upgrading is a key element of industrialisation and catch-up in developing countries. It is understood that a successful technology upgrading is linked to a coupling of global knowledge flows with local technology effort. However, the changing nature of technology and industries are challenging existing processes involved in the technology upgrading and creating new patterns of capability development. This raises the questions about factors and processes involved in technology upgrading in firms from developing countries. In this context, this paper explores the movement of Indian pharmaceutical firms from ‘small molecule generics’ towards targeting a new set of opportunities presented by the emergent biosimilar segment in the global generics market. Some leading Indian firms have adopted this technological upgrading route by making a gradual transition towards the development of biosimilar capabilities and using four case studies, this paper reveals internationalisations in form of overseas acquisitions and collaborations with MNCs formed the key basis of technology upgrading strategy for the Indian firms. This paper further shows the hiring of biotech scientists working in advanced countries increasing R&D investment and reorganisation of R&D contributed to managerial upgrading and played a significant role in creating firms' ability to absorb external knowledge.

Item Type: Journal Item
Copyright Holders: 2018 Elsevier Inc.
ISSN: 0040-1625
Project Funding Details:
Funded Project NameProject IDFunding Body
Not SetNot SetCentre for Innovation, Knowledge and Development (IKD)
Keywords: India; Technological capabilities; Internationalisation; The pharmaceutical industry; Biosimilars
Academic Unit/School: Faculty of Arts and Social Sciences (FASS) > Politics, Philosophy, Economics, Development, Geography > Development
Faculty of Arts and Social Sciences (FASS) > Politics, Philosophy, Economics, Development, Geography
Faculty of Arts and Social Sciences (FASS)
Research Group: Innovation, Knowledge & Development research centre (IKD)
Item ID: 56737
Depositing User: Dinar Kale
Date Deposited: 25 Sep 2018 15:24
Last Modified: 26 Sep 2018 09:19
URI: http://oro.open.ac.uk/id/eprint/56737
Share this page:

Metrics

Altmetrics from Altmetric

Citations from Dimensions

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU